Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

HARIT K BHATT

Allopathic & Osteopathic Physicians Ophthalmology

NPI
1447462809
CMS profile
337750
Location
OAK FOREST, IL

General Payments · PY2018–2024

$46,481.19

  • Reported across 117 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$30,528.00

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $12,549.97 32
PY2019 $495.47 8
PY2020 $1,529.82 9
PY2021 $245.52 5
PY2022 $531.90 13
PY2023 $600.51 15
PY2024 $30,528.00 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alimera Sciences, Inc. $28.81 02/09/2024 Food and Beverage Undisputed 01/23/2026 1092826048 CMS
Apellis Pharmaceuticals, Inc. $33.15 01/25/2024 Food and Beverage Undisputed 01/23/2026 1154021577 CMS
Apellis Pharmaceuticals, Inc. $33.30 04/30/2024 Food and Beverage Undisputed 01/23/2026 1154021579 CMS
Apellis Pharmaceuticals, Inc. $33.00 11/05/2024 Food and Beverage Undisputed 01/23/2026 1154021581 CMS
Astellas Pharma US Inc $20.27 07/01/2024 Food and Beverage Undisputed 01/23/2026 1139298782 CMS
Astellas Pharma US Inc $1,000.00 09/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1139418917 CMS
Astellas Pharma US Inc $17.31 10/18/2024 Food and Beverage Undisputed 01/23/2026 1139413813 CMS
Astellas Pharma US Inc $1,163.68 10/22/2024 Travel and Lodging Undisputed 01/23/2026 1139437964 CMS
Astellas Pharma US Inc $6,000.00 10/22/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1139438184 CMS
Astellas Pharma US Inc $123.26 10/22/2024 Food and Beverage Undisputed 01/23/2026 1139438528 CMS
EyePoint Pharmaceuticals US, Inc. $21.78 01/23/2024 Food and Beverage Undisputed 01/23/2026 1089507738 CMS
EyePoint Pharmaceuticals US, Inc. $123.40 03/14/2024 Food and Beverage Undisputed 01/23/2026 1089507352 CMS
EyePoint Pharmaceuticals US, Inc. $1,500.00 04/01/2024 Consulting Fee Undisputed 01/23/2026 1089507466 CMS
Genentech USA, Inc. $5.50 04/04/2024 Food and Beverage Undisputed 01/23/2026 1133018517 CMS
Genentech USA, Inc. $234.00 04/13/2024 Food and Beverage Undisputed 01/23/2026 1133018521 CMS
Genentech USA, Inc. $4,565.00 04/13/2024 Consulting Fee Undisputed 01/23/2026 1133018525 CMS
Genentech USA, Inc. $32.62 08/01/2024 Food and Beverage Undisputed 01/23/2026 1133018529 CMS
Genentech USA, Inc. $147.81 10/18/2024 Food and Beverage Undisputed 01/23/2026 1133018537 CMS
Genentech USA, Inc. $705.00 12/28/2024 Consulting Fee Undisputed 01/23/2026 1133018533 CMS
Genentech, Inc. $18.12 03/02/2024 Food and Beverage Undisputed 01/23/2026 1133018513 CMS
Harrow Eye, LLC $32.33 11/19/2024 Food and Beverage Undisputed 01/23/2026 1145598346 CMS
Hoffmann-La Roche Limited $5,360.00 10/18/2024 Consulting Fee Undisputed 01/23/2026 1133018541 CMS
Hoffmann-La Roche Limited $5.00 10/18/2024 Food and Beverage Undisputed 01/23/2026 1133018545 CMS
Hoffmann-La Roche Limited $7,448.48 11/07/2024 Consulting Fee Undisputed 01/23/2026 1133018505 CMS
Hoffmann-La Roche Limited $322.81 11/15/2024 Consulting Fee Undisputed 01/23/2026 1133018501 CMS
Hoffmann-La Roche Limited $1,118.73 11/15/2024 Consulting Fee Undisputed 01/23/2026 1133018509 CMS
Ocular Therapeutix, Inc. $14.18 08/30/2024 Food and Beverage Undisputed 01/23/2026 1148198921 CMS
Regeneron Healthcare Solutions, Inc. $117.85 01/21/2024 Food and Beverage Undisputed 01/23/2026 1114010059 CMS
Regeneron Healthcare Solutions, Inc. $120.89 04/17/2024 Food and Beverage Undisputed 01/23/2026 1114010061 CMS
Regeneron Healthcare Solutions, Inc. $20.70 05/15/2024 Food and Beverage Undisputed 01/23/2026 1114010063 CMS
Regeneron Healthcare Solutions, Inc. $39.33 06/03/2024 Food and Beverage Undisputed 01/23/2026 1114010065 CMS
Regeneron Healthcare Solutions, Inc. $26.52 08/16/2024 Food and Beverage Undisputed 01/23/2026 1114010067 CMS
Regeneron Healthcare Solutions, Inc. $30.83 11/01/2024 Food and Beverage Undisputed 01/23/2026 1114010069 CMS
Regeneron Healthcare Solutions, Inc. $35.58 11/22/2024 Food and Beverage Undisputed 01/23/2026 1114010071 CMS
Sandoz Inc. $28.76 04/15/2024 Food and Beverage Undisputed 01/23/2026 1089367682 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.